Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Streptococcus pyogenes strains in Sao Paulo, Brazil: molecular characterization as a basis for StreptInCor coverage capacity analysis

Full text
Author(s):
Show less -
de Barros, Samar Freschi [1, 2] ; De Amicis, Karine Marafigo [1, 2] ; Alencar, Raquel [1, 2] ; Smeesters, Pierre Robert [3, 4] ; Trunkel, Ariel [1, 2] ; Postol, Edilberto [1, 2] ; Almeida Junior, Joao Nobrega [5] ; Rossi, Flavia [5] ; Campos Pignatari, Antonio Carlos [6] ; Kalil, Jorge [7, 1, 2] ; Guilherme, Luiza [1, 2, 8]
Total Authors: 11
Affiliation:
[1] Univ Sao Paulo, Sch Med, Heart Inst InCor, BR-01246000 Sao Paulo - Brazil
[2] Natl Inst Sci & Technol, Inst Immunol Invest, BR-01246000 Sao Paulo - Brazil
[3] Univ Libre Bruxelles, Fac Sci, Inst Biol & Med Mol, Lab Genet & Physiol Bacterienne, B-1050 Brussels - Belgium
[4] Murdoch Childrens Res Inst, Parkville, Vic 3052 - Australia
[5] Univ Sao Paulo, Sch Med, Clin Hosp, Microbiol Lab, BR-01246000 Sao Paulo - Brazil
[6] Univ Fed Sao Paulo, Special Clin Microbiol Lab LEMC, UNIFESP, Sao Paulo - Brazil
[7] Univ Sao Paulo, Sch Med, Div Clin Immunol & Allergy, BR-01246000 Sao Paulo - Brazil
[8] Heart Inst HC FMUSP, Clin Hosp, Immunol Lab, BR-05403000 Sao Paulo - Brazil
Total Affiliations: 8
Document type: Journal article
Source: BMC INFECTIOUS DISEASES; v. 15, AUG 5 2015.
Web of Science Citations: 6
Abstract

Background: Several human diseases are caused by Streptococcus pyogenes, ranging from common infections to autoimmunity. Characterization of the most prevalent strains worldwide is a useful tool for evaluating the coverage capacity of vaccines under development. In this study, a collection of S. pyogenes strains from Sao Paulo, Brazil, was analyzed to describe the diversity of strains and assess the vaccine coverage capacity of StreptInCor. Methods: Molecular epidemiology of S. pyogenes strains was performed by emm-genotyping the 229 isolates from different clinical sites, and PCR was used for superantigen profile analysis. The emm-pattern and tissue tropism for these M types were also predicted and compared based on the emm-cluster classification. Results: The strains were fit into 12 different emm-clusters, revealing a diverse phylogenetic origin and, consequently, different mechanisms of infection and escape of the host immune system. Forty-eight emm-types were distinguished in 229 samples, and the 10 most frequently observed types accounted for 69 % of all isolates, indicating a diverse profile of circulating strains comparable to other countries under development. A similar proportion of E and A-C emm-patterns were observed, whereas pattern D was less frequent, indicating that the strains of this collection primarily had a tissue tropism for the throat. In silico analysis of the coverage capacity of StreptInCor, an M protein-conserved regionally based vaccine candidate developed by our group, had a range of 94.5 % to 59.7 %, with a mean of 71.0 % identity between the vaccine antigen and the predicted amino acid sequence of the emm-types included here. Conclusions: This is the first report of S. pyogenes strain characterization in Sao Paulo, one of the largest cities in the world; thus, the strain panel described here is a representative sample for vaccine coverage capacity analysis. Our results enabled evaluation of StreptInCor candidate vaccine coverage capacity against diverse M-types, indicating that the vaccine candidate likely would induce protection against the diverse strains worldwide. (AU)